86 related articles for article (PubMed ID: 18077030)
1. PAI-1 levels predict response to fractionated irradiation in 10 human squamous cell carcinoma lines of the head and neck.
Bayer C; Schilling D; Hoetzel J; Egermann HP; Zips D; Yaromina A; Geurts-Moespot A; Sprague LD; Sweep F; Baumann M; Molls M; Adam M
Radiother Oncol; 2008 Mar; 86(3):361-8. PubMed ID: 18077030
[TBL] [Abstract][Full Text] [Related]
2. Induction of plasminogen activator inhibitor type-1 (PAI-1) by hypoxia and irradiation in human head and neck carcinoma cell lines.
Schilling D; Bayer C; Geurts-Moespot A; Sweep FC; Pruschy M; Mengele K; Sprague LD; Molls M
BMC Cancer; 2007 Jul; 7():143. PubMed ID: 17663760
[TBL] [Abstract][Full Text] [Related]
3. Monitoring PAI-1 and VEGF levels in 6 human squamous cell carcinoma xenografts during fractionated irradiation.
Bayer C; Kielow A; Schilling D; Maftei CA; Zips D; Yaromina A; Baumann M; Molls M; Multhoff G
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e409-17. PubMed ID: 22687194
[TBL] [Abstract][Full Text] [Related]
4. Irradiation-induced regulation of plasminogen activator inhibitor type-1 and vascular endothelial growth factor in six human squamous cell carcinoma lines of the head and neck.
Artman T; Schilling D; Gnann J; Molls M; Multhoff G; Bayer C
Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):574-82. PubMed ID: 20117293
[TBL] [Abstract][Full Text] [Related]
5. Effects of hypoxia and reoxygenation on the expression levels of the urokinase-type plasminogen activator, its inhibitor plasminogen activator inhibitor type-1 and the urokinase-type plasminogen activator receptor in human head and neck tumour cells.
Sprague LD; Tomaso H; Mengele K; Schilling D; Bayer C; Stadler P; Schmitt M; Molls M
Oncol Rep; 2007 May; 17(5):1259-68. PubMed ID: 17390074
[TBL] [Abstract][Full Text] [Related]
6. Effect of reoxygenation on the hypoxia-induced up-regulation of serine protease inhibitor PAI-1 in head and neck cancer cells.
Sprague LD; Mengele K; Schilling D; Geurts-Moespot A; Sweep FC; Stadler P; Schmitt M; Molls M
Oncology; 2006; 71(3-4):282-91. PubMed ID: 17671400
[TBL] [Abstract][Full Text] [Related]
7. Pre-treatment number of clonogenic cells and their radiosensitivity are major determinants of local tumour control after fractionated irradiation.
Yaromina A; Krause M; Thames H; Rosner A; Krause M; Hessel F; Grenman R; Zips D; Baumann M
Radiother Oncol; 2007 Jun; 83(3):304-10. PubMed ID: 17517444
[TBL] [Abstract][Full Text] [Related]
8. Pimonidazole labelling and response to fractionated irradiation of five human squamous cell carcinoma (hSCC) lines in nude mice: the need for a multivariate approach in biomarker studies.
Yaromina A; Zips D; Thames HD; Eicheler W; Krause M; Rosner A; Haase M; Petersen C; Raleigh JA; Quennet V; Walenta S; Mueller-Klieser W; Baumann M
Radiother Oncol; 2006 Nov; 81(2):122-9. PubMed ID: 16956683
[TBL] [Abstract][Full Text] [Related]
9. Impact of the tumour bed effect on microenvironment, radiobiological hypoxia and the outcome of fractionated radiotherapy of human FaDu squamous-cell carcinoma growing in the nude mouse.
Zips D; Eicheler W; Brüchner K; Jackisch T; Geyer P; Petersen C; van der Kogel AJ; Baumann M
Int J Radiat Biol; 2001 Dec; 77(12):1185-93. PubMed ID: 11747543
[TBL] [Abstract][Full Text] [Related]
10. Urokinase-type plasminogen activator, plasminogen activator inhibitor type 1 and cathepsin D: analysis of their prognostic significance in squamous cell carcinoma of the head and neck.
Strojan P; Budihna M; Smid L; Vrhovec I; Skrk J
Anticancer Res; 2000; 20(5C):3975-81. PubMed ID: 11268487
[TBL] [Abstract][Full Text] [Related]
11. [Expression and significance of the urokinase-type plasminogen activator and its inhibitors in squamous cell carcinoma of human larynx].
Zhao EM; Han DM; Yu ZK; Fan EZ; Li Y
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2003 Feb; 38(1):39-42. PubMed ID: 12778766
[TBL] [Abstract][Full Text] [Related]
12. Changes in the fraction of total hypoxia and hypoxia subtypes in human squamous cell carcinomas upon fractionated irradiation: evaluation using pattern recognition in microcirculatory supply units.
Maftei CA; Bayer C; Shi K; Astner ST; Vaupel P
Radiother Oncol; 2011 Oct; 101(1):209-16. PubMed ID: 21641070
[TBL] [Abstract][Full Text] [Related]
13. [Prognostic value of the urokinase-type plasminogen activator and its inhibitors in squamous cell carcinoma of human larynx].
Zhao E; Han D; Yu Z; Fan E; Li Y; Zhou Z
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2002 Nov; 16(11):599-602. PubMed ID: 15515548
[TBL] [Abstract][Full Text] [Related]
14. Measurement of reoxygenation during fractionated radiotherapy in head and neck squamous cell carcinoma xenografts.
Harriss W; Bezak E; Yeoh E; Hermans M
Australas Phys Eng Sci Med; 2010 Sep; 33(3):251-63. PubMed ID: 20878297
[TBL] [Abstract][Full Text] [Related]
15. Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition.
Pinsky DJ; Liao H; Lawson CA; Yan SF; Chen J; Carmeliet P; Loskutoff DJ; Stern DM
J Clin Invest; 1998 Sep; 102(5):919-28. PubMed ID: 9727060
[TBL] [Abstract][Full Text] [Related]
16. Clinical evidence for correlation of insufficient tissue oxygen supply (hypoxia) and tumor-associated proteolysis in squamous cell carcinoma of the head and neck.
Stadler P; Feldmann HJ; Creighton C; Zeilhoffer HF; Zimmermann V; Schmitt M; Molls M
Int J Biol Markers; 2000; 15(3):235-6. PubMed ID: 11012100
[TBL] [Abstract][Full Text] [Related]
17. Core needle biopsies for determination of the microenvironment in individual tumours for longitudinal radiobiological studies.
Yaromina A; Eckardt A; Zips D; Eicheler W; Schuetze C; Thames H; Baumann M
Radiother Oncol; 2009 Sep; 92(3):460-5. PubMed ID: 19682759
[TBL] [Abstract][Full Text] [Related]
18. Connexin 32 down-regulates the fibrinolytic factors in metastatic renal cell carcinoma cells.
Hagiwara H; Sato H; Shirai S; Kobayashi S; Fukumoto K; Ishida T; Seki T; Ariga T; Yano T
Life Sci; 2006 Apr; 78(19):2249-54. PubMed ID: 16289236
[TBL] [Abstract][Full Text] [Related]
19. Does heterogeneity of pimonidazole labelling correspond to the heterogeneity of radiation-response of FaDu human squamous cell carcinoma?
Yaromina A; Hölscher T; Eicheler W; Rosner A; Krause M; Hessel F; Petersen C; Thames HD; Baumann M; Zips D
Radiother Oncol; 2005 Aug; 76(2):206-12. PubMed ID: 16024121
[TBL] [Abstract][Full Text] [Related]
20. Tumour cell proliferation under hypoxic conditions in human head and neck squamous cell carcinomas.
Wijffels KI; Marres HA; Peters JP; Rijken PF; van der Kogel AJ; Kaanders JH
Oral Oncol; 2008 Apr; 44(4):335-44. PubMed ID: 17689286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
